Vedolizumab may be an effective option for the treatment of postoperative recurrence of Crohn's disease
Fabio Salvatore Macaluso, Maria Cappello, Federica Crispino, Mauro Grova, Antonino Carlo Privitera, Giovita Piccillo, Antonio Magnano, Concetta Ferracane, Nunzio Belluardo, Emiliano Giangreco, Walter Fries, Anna Viola, Roberto Di Mitri, Filippo Mocciaro, S. Camilleri, Serena Garufi, Sara Renna, Angelo Casà, Marcello Maida, Ambrogio Orlando
Topics & Concepts
MedicineVedolizumabColonoscopyCrohn's diseaseSurgeryClinical endpointInternal medicineCohortDiseaseRandomized controlled trialColorectal cancerCancerInflammatory Bowel DiseaseMicroscopic ColitisCeliac Disease Research and Management